2 Months on Tirzepitide
US$ 20.75
novo nordisk is cutting prices on its popular glp-1 drugs. cuts 70%, but semaglutide revenue could grow in 2026 Generic drug companies rework pricing
Description
Advertising on our site helps support our mission
The active ingredient in semaglutide GLP-1 injections is a type of GLP-1 receptor agonist
PD is another common degenerative disease, and the main pathology is the degeneration and death of dopaminergic (DA) neurons in the substantia nigra of the midbrain, which leads to a significant decrease in DA content in the striatum
Diabetes Obes Metab 23(9):21162124
le Roux CW, Astrup A, Fujioka K, et al
BMJ 347 , f5934 (2013)
